Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,646.40
(
1.31%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
110.57
(
-1.61%
)
Bitcoin
75,714.65
(
-0.08%
)
News Focus
News Focus
Post# of 257470
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122909
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: randychub post# 218636

Friday, 04/20/2018 8:07:56 PM

Friday, April 20, 2018 8:07:56 PM

Post# of 257470

RVNC—Can attaching their peptide to other drugs for [longer]-lasting effect also be in the future?

Even if it could be done technologically, it wouldn’t make sense from a business standpoint, IMO. There are manifold biotech companies who specialize in reformulating existing drugs, so RVNC can almost certainly realize a higher return on investment by focusing on RT002.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up